NIH expands trials of convalescent plasma against Covid-19
The Covid-19 trials are expected to enrol approximately 1,000 participants. Credit: Pete Linforth from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more